Preclinical studies using in vitro-transcribed mRNA chimeric antigen receptor T cells (IVT mRNA CAR T) have shown effective, targeted cytotoxicity against various hematologic cancers, including CLL, acute lymphoblastic leukemia, and acute myeloid leukemia (AML), as well as solid tumors including mesothelioma, ovarian cancer, breast cancer, neuroblastoma, glioblastoma (GBM), and melanoma
Although these initial studies directly manipulate GLP-1R or GLP-1, other ways to influence the GLP-1 pathway are less studied
Our approach centers on a highly specific antibody we call anti-CRH
But it took 75 years to change that story with tobacco
Approved April 2026
By Age Group: The segmentation covers 18-34, 35-54, 55-74, and 75+ age brackets